Gemcitabine as a single-agent treatment for ovarian cancer.

Abstract

OBJECTIVE Gemcitabine has shown therapeutic activity in a variety of malignancies, including ovarian cancer. This review summarizes both published and unpublished data on the use of gemcitabine as a single agent in the treatment of ovarian cancer. METHODS The results of eight clinical trials of gemcitabine in women with advanced (stage III or IV) ovarian… (More)

Topics

  • Presentations referencing similar topics